Psychopathology and extrapyramidal side effects in smoking and non-smoking patients with schizophrenia: Systematic review and meta-analysis of comparative studies

Hui Huang, Min Dong, Ling Zhang, Bao Liang Zhong, Chee H. Ng, Gabor S. Ungvari, Zhen Yuan, Xiangfei Meng, Yu Tao Xiang

Research output: Contribution to journalArticle

Abstract

The association between smoking and psychopathology and extrapyramidal side effects (EPSE) in schizophrenia has been controversial. This systematic review and meta-analysis compared psychopathology and EPSE between smoking and non-smoking schizophrenia patients. The PubMed, EMBASE, PsycINFO, Cochrane Library, and Web of Science databases were independently and systematically searched by two researchers to identify relevant articles. Standardized mean differences (SMDs) and their 95% confidence intervals (CI) were calculated with random effect models. Subgroup and meta-regression analyses were performed to explore sources of heterogeneity. The systematic review and meta-analysis included 29 studies that compared psychotic, depressive and anxiety symptoms and EPSE between smoking (n = 3591) and non-smoking schizophrenia patients (n = 2980). Smoking patients had significantly more severe positive symptoms (24 studies; SMD = 0.33, 95% CI: 0.16 to 0.50, P < 0.001), but less severe EPSE (7 studies; SMD = −0.20, 95% CI: −0.38 to −0.02, P = 0. 03). No significant group differences in negative, depressive and anxiety symptoms were found. In conclusion, this systematic review and meta-analysis found that smoking schizophrenia patients had more severe positive symptoms but less severe EPSE than non-smoking patients.

Original languageEnglish
Pages (from-to)476-482
Number of pages7
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume92
DOIs
Publication statusPublished - 8 Jun 2019

Fingerprint

Psychopathology
Meta-Analysis
Schizophrenia
Smoking
Confidence Intervals
Anxiety
Library Science
Depression
PubMed
Regression Analysis
Research Personnel
Databases

Cite this

@article{1c80e790de93451f9cb9f5a04a63035d,
title = "Psychopathology and extrapyramidal side effects in smoking and non-smoking patients with schizophrenia: Systematic review and meta-analysis of comparative studies",
abstract = "The association between smoking and psychopathology and extrapyramidal side effects (EPSE) in schizophrenia has been controversial. This systematic review and meta-analysis compared psychopathology and EPSE between smoking and non-smoking schizophrenia patients. The PubMed, EMBASE, PsycINFO, Cochrane Library, and Web of Science databases were independently and systematically searched by two researchers to identify relevant articles. Standardized mean differences (SMDs) and their 95{\%} confidence intervals (CI) were calculated with random effect models. Subgroup and meta-regression analyses were performed to explore sources of heterogeneity. The systematic review and meta-analysis included 29 studies that compared psychotic, depressive and anxiety symptoms and EPSE between smoking (n = 3591) and non-smoking schizophrenia patients (n = 2980). Smoking patients had significantly more severe positive symptoms (24 studies; SMD = 0.33, 95{\%} CI: 0.16 to 0.50, P < 0.001), but less severe EPSE (7 studies; SMD = −0.20, 95{\%} CI: −0.38 to −0.02, P = 0. 03). No significant group differences in negative, depressive and anxiety symptoms were found. In conclusion, this systematic review and meta-analysis found that smoking schizophrenia patients had more severe positive symptoms but less severe EPSE than non-smoking patients.",
keywords = "Meta-analysis, Psychopathology, Schizophrenia, Smoke, Systematic review",
author = "Hui Huang and Min Dong and Ling Zhang and Zhong, {Bao Liang} and Ng, {Chee H.} and Ungvari, {Gabor S.} and Zhen Yuan and Xiangfei Meng and Xiang, {Yu Tao}",
year = "2019",
month = "6",
day = "8",
doi = "10.1016/j.pnpbp.2019.02.011",
language = "English",
volume = "92",
pages = "476--482",
journal = "Progress in Neuro-Psychopharmacology & Biological Psychiatry",
issn = "1878-4216",
publisher = "Elsevier",

}

Psychopathology and extrapyramidal side effects in smoking and non-smoking patients with schizophrenia : Systematic review and meta-analysis of comparative studies. / Huang, Hui; Dong, Min; Zhang, Ling; Zhong, Bao Liang; Ng, Chee H.; Ungvari, Gabor S.; Yuan, Zhen; Meng, Xiangfei; Xiang, Yu Tao.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 92, 08.06.2019, p. 476-482.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Psychopathology and extrapyramidal side effects in smoking and non-smoking patients with schizophrenia

T2 - Systematic review and meta-analysis of comparative studies

AU - Huang, Hui

AU - Dong, Min

AU - Zhang, Ling

AU - Zhong, Bao Liang

AU - Ng, Chee H.

AU - Ungvari, Gabor S.

AU - Yuan, Zhen

AU - Meng, Xiangfei

AU - Xiang, Yu Tao

PY - 2019/6/8

Y1 - 2019/6/8

N2 - The association between smoking and psychopathology and extrapyramidal side effects (EPSE) in schizophrenia has been controversial. This systematic review and meta-analysis compared psychopathology and EPSE between smoking and non-smoking schizophrenia patients. The PubMed, EMBASE, PsycINFO, Cochrane Library, and Web of Science databases were independently and systematically searched by two researchers to identify relevant articles. Standardized mean differences (SMDs) and their 95% confidence intervals (CI) were calculated with random effect models. Subgroup and meta-regression analyses were performed to explore sources of heterogeneity. The systematic review and meta-analysis included 29 studies that compared psychotic, depressive and anxiety symptoms and EPSE between smoking (n = 3591) and non-smoking schizophrenia patients (n = 2980). Smoking patients had significantly more severe positive symptoms (24 studies; SMD = 0.33, 95% CI: 0.16 to 0.50, P < 0.001), but less severe EPSE (7 studies; SMD = −0.20, 95% CI: −0.38 to −0.02, P = 0. 03). No significant group differences in negative, depressive and anxiety symptoms were found. In conclusion, this systematic review and meta-analysis found that smoking schizophrenia patients had more severe positive symptoms but less severe EPSE than non-smoking patients.

AB - The association between smoking and psychopathology and extrapyramidal side effects (EPSE) in schizophrenia has been controversial. This systematic review and meta-analysis compared psychopathology and EPSE between smoking and non-smoking schizophrenia patients. The PubMed, EMBASE, PsycINFO, Cochrane Library, and Web of Science databases were independently and systematically searched by two researchers to identify relevant articles. Standardized mean differences (SMDs) and their 95% confidence intervals (CI) were calculated with random effect models. Subgroup and meta-regression analyses were performed to explore sources of heterogeneity. The systematic review and meta-analysis included 29 studies that compared psychotic, depressive and anxiety symptoms and EPSE between smoking (n = 3591) and non-smoking schizophrenia patients (n = 2980). Smoking patients had significantly more severe positive symptoms (24 studies; SMD = 0.33, 95% CI: 0.16 to 0.50, P < 0.001), but less severe EPSE (7 studies; SMD = −0.20, 95% CI: −0.38 to −0.02, P = 0. 03). No significant group differences in negative, depressive and anxiety symptoms were found. In conclusion, this systematic review and meta-analysis found that smoking schizophrenia patients had more severe positive symptoms but less severe EPSE than non-smoking patients.

KW - Meta-analysis

KW - Psychopathology

KW - Schizophrenia

KW - Smoke

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=85062455757&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2019.02.011

DO - 10.1016/j.pnpbp.2019.02.011

M3 - Article

VL - 92

SP - 476

EP - 482

JO - Progress in Neuro-Psychopharmacology & Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology & Biological Psychiatry

SN - 1878-4216

ER -